Found 455 results in Expert Content

Summary: Catalent specializes in small molecule solid-state characterization, leveraging a vast network of scientists for successful drug candidate development by choosing the best API form.

Summary: Catalent has supported drug development since 1991, focusing on E&L. They use well-characterized materials to ensure drug product safety and quality.

Summary: Whether you are looking for accelerated development for your novel therapy, to transform your concepts into differentiated products to grow your brand, or lifecycle management to extend market share and maximize product value, Catalent can be your...

Gain valuable insights into the benefits of Zydis fast-dissolve technology and how it can optimize your product for commercial success.

Summary: This article discusses how to effectively classify highly potent APIs (HPAPIs), and to help develop containment protocols and manufacturing processes that are both safe and efficient.

Summary: This webinar aims to address the specific needs of sponsors by providing valuable insights and practical strategies. Experts will explore...

Summary: Zydis ODT offers rapid disintegration, a good mouthfeel and pleasant taste which plays a role in improving patient engagement in their treatment programs and offers an easy-to-take alternative to conventional oral tablets to help meet the needs of specific patient populations such as pediatric, geriatric and dysphagic patients.

Gain insight into how to properly assess and categorize HPAPIs to develop an appropriate containment strategy to manufacture them safely.

Summary: During this webinar learn with the right combination of technology and expertise, micronization can help to overcome many of the challenges faced by small molecule drugs and address the challenges and solutions to scale, yield and cost of goods.

Summary: In this webinar, experts offer insights into the perceived barriers to developing LBFs and recent advances in translating them into useful clinical and commercial products of lipophilic drugs.